U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07450430) titled 'Optimal Timing of Ketamine Initiation for SCD Pain' on Jan. 13.
Brief Summary: The goal of this clinical trial is to learn if the use of early ketamine decreases the chance of admission to the hospital in patients with sickle cell disease presenting with pain.
The main questions this study aims to answer are:
* Does ketamine given within 1 hour of acute care presentation decrease the chance of hospital admission?
* If admitted, does continuing ketamine in the first few hours of admission decrease opioid use or length of stay compared to those who start it later in the admission?
Researchers will compare the study arm to patients...